HIV/AIDS Vaccines: 2018
Abstract
Human immunodeficiency virus (HIV) has infected 76 million people and killed an estimated 35 million. During its 40‐year history, remarkable progress has been made on antiretroviral drugs. Progress toward a vaccine has also been made, although this has yet to deliver a licensed product. In 2007, I wrote a review, HIV AIDS Vaccines: 2007. This review, HIV AIDS Vaccines: 2018, focuses on the progress in the past 11 years. I begin with key challenges for the development of an AIDS vaccine and the lessons learned from the six completed efficacy trials, only one of which has met with some success.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 09, 2018
- Source ID
- 10.1002/cpt.1208
Entities
People
- Harriet L. Robinson